Mechanism of the neuroleptic-induced obesity in female rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 1, 1998, Pages 187-198

  Baptista, Trino ^a,b   Contreras, Quilianio ^a   Teneud, Luis ^a   Albornoz, María A ^a   Acosta, Arnaldo ^a   Páez, Ximena ^a   De Quijada, Mary ^a   Lacruz, Anny ^a   Hernández, Luis ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b NONE   (Venezuela)

Author keywords

Blood lipids; Estradiol; Hyperphagia; Neuroleptics; Obesity; Prolactin; Rats; Serum glucose; Sulpiride

Indexed keywords

CARBOHYDRATE; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NEUROLEPTIC AGENT; PROLACTIN; SULPIRIDE;

ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HYPERPHAGIA; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OBESITY; RAT; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENERGY INTAKE; ESTRADIOL; FEMALE; HUMANS; OBESITY; PROLACTIN; RATS; RATS, WISTAR; SULPIRIDE; TRIGLYCERIDES; WEIGHT GAIN;

EID: 0031906194     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(97)00101-2     Document Type: Article

References (26)

1. ATAYA, K., MERCADO, A., KARTAGINER, J., ABBASI, J. and MOGHISSI, K.S. (1988). Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. & Steril. 50: 876-881.
2. BALDESSARINI, R.J. (1996). Drugs and the the treatment of psychiatric disorders: psychosis and anxiety. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, P.B. Molinoff, P.B, R.W. Ruddon, A. Goodman Gilman (Eds.), pp. 399-427, McGraw-Hill, New York.
3. 2 dopamine receptors involved ? Pharmacol. Biochem. Behav. 27: 399-405.
4. BAPTISTA, T., PARADA, M.A. and MURZI, E. (1988) Puberty modifies sulpiride effects on body weight in rats. Neurosci. Lett. 92: 161-164.
5. 2 dopamine receptors supersensitivity ? Med Hypoth. 30: 5-8.
6. BAPTISTA, T., HERNANDEZ, L. and HOEBEL, B.G. (1990) Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus. Pharmacol. Biochem. Behav. 37: 227-229.
7. BAPTISTA, T., TENEUD, L. and HERNANDEZ, L. (1993) Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats. Pharmacol. Biochem. Behav. 45: 45-49.
8. BAPTISTA, T., TENEUD, L., CONTRERAS, Q., ALASTRE, T., BURGUERA, J.L., BURGUERA, M. de BAPTISTA, E., WEISS, S.R.B. and HERNANDEZ, L. (1995) Lithium and body weight gain. Pharmacopsychiat. 28: 35-44.
9. BAPTISTA, T., CALANCHE, I., de QUIJADA, M., CONTRERAS, Q., MARTINEZ, J.L. and HERNANDEZ, L. (1996) Endocrine effects of neuroleptics and body weight gain: a study in normal female subjects. Neurosci. Soc. Abs. pp. 459.
10. BERNSTEIN, J.G. (1992) Management of psychotropic drug-induced obesity. In:Obesity, P. Björntrop. and B.N. Brodoff. (Eds.), pp. 445-453, J.B. Lippincott Company, Philadelphia.
11. CABRERA, R., MAYOR, P., FERNANDEZ-RUIZ, J. and CALLE, C. (1988) Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia. Mol. Cell Endocrinol. 58: 167-173.
12. CORREA, N., OPLER, L.A., KAY, S.R. and BIRMAHER, B. (1987) Amantadine in the treatment of neuroenocrine side effects of neuroleptics. J. Clin. Psychopharmacol. 7: 91-95.
13. DORRINGTON, J. and GORE-LANGTON, R.E. (1981) Prolactin inhibits oestrogen synthesis in the ovary. Nature. 290: 600-602.
14. ERLE, G., BASSO, M., FEDERSPIL, G., SICOLO, N.and SCANDELLARI, C. (1977)Effeet of chlorpromazine on blood glucose and plasma insulin in man.Eur. J. Clin. Pharmacol. 11: 15-18.
15. HAN, P.W. and LIU, A.C. (1966) Obesity and impaired growth of rats force-fed 40 days after hypothalamic lesions. Am J Physiol. 211: 229-231.
16. JOHNSON, R.D. (1995) Opioid involvement in feeding behavior and the pathogenesis of certain eating disorders. Med. Hypoth. 45: 491-497.
17. JOKINEN, M.P., CLARKSON T.B., and PRICHARD, R.W. (1985) Animal models in atherosclerosis research. Exp Mol Pathol. 42: 1-28.
18. KISSEBAH, A.H. and KRAKOVER, G.R. (1994) Regional adiposity and morbidity. Physiol. Rev. 74: 761-798.
19. NATIONAL CHOLESTEROL EDUCATION PROGRAM. (1994) Adult Treatment Panel II.Circulation. 89: 1336-1432.
20. OADES, R.D. and SCHEPKER, R. (1994) Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinol. 19: 373-385.
21. PARADA, M.A., HERNANDEZ, L. and HOEBEL, B.G. (1988) Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol. Biochem. Behav. 30: 917-923.
22. PARADA, M.A., HERNANDEZ, L., PAEZ, X., BAPTISTA, T., PUIG DE PARADA, M., and DE QUIJADA, M. (1989) Mechanism of the body weight increase induced by systemic sulpiride. Pharmacol. Biochem. Behav. 33: 45-50.
23. ROBINSON, R.G., McHUGH, P.R. and FOLSTEIN, M.F. (1975) Measurement of appetite disturbances in psychiatric disorders. J. Psychiat. Res. 12: 59-68.
24. SCALLET, A.C. and OLNEY, J.W. (1986) Components of hypothalamic obesity: biperidyl-mustard lesionsadd hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Res. 374: 380-386.
25. WADE, G.N. and SCHNEIDER, J.E. (1992) Metabolic fuels and reproduction in female mammals. Neurosci. Biobehav. Rev. 16: 235-272.
26. WAGSTAFF, A.J., FITTON, A. and BENFIELD, P. (1994) Sulpiride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in schizophrenia. CNS Drugs. 2: 313-333.